NIPT

• Introduction:
  Non-invasive prenatal testing (NIPT) is a diagnostic method used to assess the risk of genetic conditions in a fetus without the need for invasive procedures like amniocentesis.

• Technology:
  NIPT analyzes small fragments of fetal DNA circulating in the mother's blood, using advanced sequencing or genetic analysis techniques to detect chromosomal abnormalities such as Down syndrome.

• Advantages:
  We conduct sequencing on High-throughput DNA Sequencing Platform . Accurate High-fidelity sequencing chemistry and unique optical system Cost Effective Competitive instrument and reagent kit prices Single-flow cell and dual-flow cell mode give customer more control over per-sample cost.

• Applications:
  NIPT is primarily used to screen for common chromosomal conditions like Down syndrome, trisomy 18, and trisomy 13, and can also provide information on the fetal sex and certain microdeletions.

• Impact:
  NIPT has revolutionized prenatal care by providing an early, safe, and reliable alternative to invasive testing, reducing the need for more invasive procedures and giving parents peace of mind.

TB-tNGS

• Drug-resistant TB (DR-TB) refers to a TB infection that is resistant to one or more anti-TB drugs.

• The ability of TB to resist anti-TB drugs represents a major barrier to TB diagnostic, treatment, and eradication efforts.

• Since Mtb is continually adapting to new anti-TB drugs and evolving cognate resistance mutations, there is a need for a faster and more accurate method to distinguish drug-resistance properties.

• NGS is fueling the future of the DR-TB research landscape. targetedNGS workflows can be applied to TB genomic investigation, providing crucial and precise TB detection and drug resistance profiling. that can help doctors to make the best decisions on multiple and extensively drug-resistant tuberculosis (M/XDR-TB) treatment plans in time.

WES

• Introduction: Whole exome sequencing (WES) is a genomic technique that sequences all the protein-coding regions of the genome, known as exons, to identify genetic variants associated with diseases.

• Technology: WES utilizes next-generation sequencing (NGS) technology to capture and sequence the exonic regions, providing a comprehensive analysis of the genetic makeup.

  
  

• Advantages: WES is more cost-effective than whole-genome sequencing, while still offering detailed insights into genetic mutations related to diseases, particularly rare genetic disorders.

  
  

• Applications: WES is widely used in clinical diagnostics, personalized medicine, cancer research, and identifying genetic causes of inherited diseases.

  
  

• Impact: WES has revolutionized the diagnosis and treatment of genetic diseases, enabling targeted therapies and advancing precision medicine.